Hepatitis C Testing in VA Community-Based Outpatient Clinics

Overview

The VISN1 VA Hepatitis C Testing and Linkage to Care Quality Improvement project aims to increase the proportion of Veterans tested for HCV in those born between 1945-1965 and in vulnerable, high-risk groups.

Full Title of Study: “Hepatitis C Testing in VA Community-Based Outpatient Clinics (QUE 15-284)”

Study Type

  • Study Type: Interventional
  • Study Design
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Diagnostic
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2016

Detailed Description

The VISN1 VA Hepatitis C Testing and Linkage to Care Quality Improvement project aims to: (1) increase the proportion of Veterans tested for HCV in those born between 1945-1965 and in vulnerable, high-risk groups, (2) Increase linkage to specialized HCV care among VISN 1 VA Veterans diagnosed with HCV infection, and (3) Evaluate whether race, ethnicity, gender, or other markers of social disparity influence completion of HCV testing and linkage to specialty care, and whether disparities are reduced by the planned VISN 1 VA HCV Quality Improvement (QI) program. The central focus is to reduce delays in diagnosis and linkage to treatment evaluation, management of comorbidities and contraindications, and subsequent initiation.

Interventions

  • Other: quality improvement intervention
    • The intervention activities included: assessment, planning, stakeholder engagement, education, ongoing process monitoring, program adaptation, problem identification and problem solving, data audit/feedback, program marketing, network development, among others.

Arms, Groups and Cohorts

  • Experimental: quality improvement intervention
    • The intervention activities included: assessment, planning, stakeholder engagement, education, ongoing process monitoring, program adaptation, problem identification and problem solving, data audit/feedback, program marketing, network development, among others.

Clinical Trial Outcome Measures

Primary Measures

  • HCV Antibody Test
    • Time Frame: within 30 days of outpatient primary care visit
    • Number of Participants with HCV Antibody Test

Participating in This Clinical Trial

Inclusion Criteria

  • Veterans
  • Born in the period of 1945-1965 ("birth cohort")
  • With an outpatient visit in primary care at a VISN1 facility in FY 2016

Exclusion Criteria

  • N/A

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • VA Office of Research and Development
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Allen L. Gifford, MD, Principal Investigator, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
    • Mari-Lynn Drainoni, PhD, Principal Investigator, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.